Methotrexate reduces cardiovascular risk in patients with inflammatory disease but not in the general population. Methotrexate (MTX) reduces cardiovascular risk in patients with rheumatoid arthritis ...
Cardiovascular disease can be managed with drugs that take various approaches, but few of them work by reducing inflammation. Novartis is getting an anti-inflammatory drug candidate through its $1.4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback